Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
L-cysteic acid is a non-proteinogenic sulfur-containing amino acid and the L-enantiomer of cysteic acid. It is an oxidation product of L-cysteine and features a C-terminal sulfonic acid group. Naturally occurring in human hair and sheep wool exposed to environmental factors, it serves as a metabolite in both humans and bacteria such as Escherichia coli[1][2]. In research settings, L-cysteic acid is used as an amino sulfonic acid derivative for peptide synthesis, biochemical studies on protein synthesis and enzyme activity, neuroscience investigations into neurotransmitter systems (notably as an agonist at several metabotropic glutamate receptors), and pharmaceutical development targeting oxidative stress or inflammation[4][5]. It also finds applications in food science for its antioxidant properties and in cosmetics for potential skin health benefits[4]. Mechanistically, it can act as a competitive inhibitor of the bacterial aspartate:alanine antiporter (AspT) and functions as an agonist at certain metabotropic glutamate receptors (mGluRs) in animal models[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on L-cysteic acid.